Management and prevention of recurrent clostridium difficile infection in patients after total joint arthroplasty: a review
- PMID: 23569710
- PMCID: PMC3598518
- DOI: 10.1177/2151458513479023
Management and prevention of recurrent clostridium difficile infection in patients after total joint arthroplasty: a review
Abstract
Clostridium difficile infection (CDI) is the most common infectious cause of nosocomial diarrhea in elderly patients, accounting for 15% to 25% of all cases of antibiotic-induced diarrhea in those patients. Virulent forms of this organism have developed, increasing the associated morbidity, mortality, and complication rates. The average patient undergoing total joint arthroplasty is at particular risk of CDI because of advanced age, the use of prophylactic antibiotic coverage in the perioperative period, multiple comorbid conditions, and length of hospital stay. In addition, patients who have had one CDI are at risk of another; the rate of recurrent CDI (RCDI) is 15% to 30%. To review the available information on RCDI, we conducted an extensive literature search, focusing on its epidemiology and the management strategies for its treatment and prevention. We found the management of RCDI is a controversial topic, with as yet no consensus regarding specific treatment guidelines. Several experienced clinicians have published suggested treatment algorithms, but they are based on anecdotal experience. With regard to the prevention of RCDI, the literature is scarce, and currently, the only effective strategies remain judicious use of perioperative antibiotics and appropriate implementation of infection control procedures. There are several vaccination medications that are currently being studied but are not yet ready for clinical use. We agree with the approach to management of RCDI that has been proposed in several articles, that is, on confirmation of a first recurrence of CDI by a stool toxin assay and clinical symptoms, a 14-day course of metronidazole or vancomycin; for a second recurrence, a tapered-pulsed course of vancomycin; and, for 3 or more recurrences, a repeat course of the tapered-pulsed vancomycin and adjunctive Saccharomyces boulardii or cholestyramine.
Keywords: Clostridium difficile; arthroplasty; infection; recurrent.
Conflict of interest statement
Similar articles
-
Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials.Anaerobe. 2020 Feb;61:102098. doi: 10.1016/j.anaerobe.2019.102098. Epub 2019 Sep 4. Anaerobe. 2020. PMID: 31493500
-
Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.Drugs Aging. 2015 Aug;32(8):639-47. doi: 10.1007/s40266-015-0289-2. Drugs Aging. 2015. PMID: 26233437 Review.
-
Clostridium difficile infection in older adults: a review and update on its management.Am J Geriatr Pharmacother. 2012 Feb;10(1):14-24. doi: 10.1016/j.amjopharm.2011.12.004. Epub 2012 Jan 20. Am J Geriatr Pharmacother. 2012. PMID: 22260856 Review.
-
Best strategies in recurrent or persistent Clostridium difficile infection.Surg Infect (Larchmt). 2011 Jun;12(3):235-9. doi: 10.1089/sur.2010.080. Epub 2011 Jul 18. Surg Infect (Larchmt). 2011. PMID: 21767157 Review.
-
Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.Anaerobe. 2013 Dec;24:20-4. doi: 10.1016/j.anaerobe.2013.08.007. Epub 2013 Sep 4. Anaerobe. 2013. PMID: 24012687
Cited by
-
Systematic review and meta-analysis of randomized controlled trials of antibiotics and antiseptics for preventing infection in people receiving primary total hip and knee prostheses.Antimicrob Agents Chemother. 2015 Nov;59(11):6696-707. doi: 10.1128/AAC.01331-15. Epub 2015 Aug 10. Antimicrob Agents Chemother. 2015. PMID: 26259793 Free PMC article.
References
-
- Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009. Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf Accessed August 29, 2012 - PubMed
-
- Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol. 2011;32(4):387–390 - PubMed
-
- Barbut F, Jones G, Eckert C. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis. 2011;24(4):370–376 - PubMed
-
- Kelly CP, LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med. 2008;359(18):1932–1940 - PubMed
LinkOut - more resources
Full Text Sources